A review of the epidemiology of human breast cancer

Epidemiologic Reviews

Volumn 1, Issue 1, 1979, Pages 74-109

  Kelsey, Jennifer L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; GONADOTROPIN; HAIR DYE; HORMONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; PROLACTIN; RESERPINE; THYROID HORMONE; TREATMENT; DYE;

ADULT; AGE; BIOLOGY; BREAST CANCER--WOMEN; BREAST DISEASE; BREAST TUMOR; CANCER; CAUCASIAN; CULTURAL BACKGROUND; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRY; DIET; DISEASES; ETHNIC GROUP; EUROPE; FEMALE; FIBROCYSTIC BREAST DISEASE; GENETICS; HUMAN; INCIDENCE; JAPAN; LITERATURE REVIEW; MALE; MAMMOGRAPHY; MEASUREMENT; MORTALITY--WOMEN; MULTIPLE CANCER; NEGRO; NEOPLASM; NORTH AMERICA; NORTHERN AMERICA; NUTRITION; ONCOVIRINAE; PARITY; PHYSIOLOGY; POPULATION; POPULATION AND POPULATION RELATED PHENOMENA; POPULATION DYNAMICS; RADIATION INJURY; RESEARCH METHODOLOGY; REVIEW; UNITED STATES; WESTERN HEMISPHERE; BREAST; BREAST CANCER; CANCER EPIDEMIOLOGY; ENDOCRINE SYSTEM; EPIDEMIOLOGY; ETIOLOGY; FAMILIAL DISEASE; GEOGRAPHIC DISTRIBUTION; HEREDITY; RADIATION EXPOSURE; SCREENING; SEX DIFFERENCE; SHORT SURVEY; SOCIOECONOMICS; VIRUS INFECTION;

AGE FACTORS; AMERICAS; ANDROGENS; BIOLOGY; BLACKS; BREAST CANCER--WOMEN; CANCER; CULTURAL BACKGROUND; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; DISEASES; ESTROGENS; ETHNIC GROUPS; GENETICS; GONADOTROPINS, PITUITARY; HORMONES; INCIDENCE; LITERATURE REVIEW; MEASUREMENT; MORTALITY--WOMEN; NEOPLASMS; NORTH AMERICA; NORTHERN AMERICA; NUTRITION; POPULATION; POPULATION CHARACTERISTICS; POPULATION DYNAMICS; PROGESTERONE; PROLACTIN; RESEARCH METHODOLOGY; TREATMENT; UNITED STATES; WHITES;

ADULT; ANDROGENS; BREAST DISEASES; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL; DIET; ESTROGENS; EUROPE; FEMALE; FIBROCYSTIC DISEASE OF BREAST; HAIR DYES; HUMAN; JAPAN; MALE; MAMMOGRAPHY; MIDDLE AGE; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, RADIATION-INDUCED; ONCOGENIC VIRUSES; PARITY; PROGESTERONE; PROLACTIN; RESERPINE; THYROID HORMONES; UNITED STATES;

EID: 0018653772     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a036215     Document Type: Article

References (358)

1. MacMahon B, Cole P, Brown J: Etiology of human breast cancer: A review. J Natl Cancer Inst 50:21-42, 1973
2. SEER Program: Cancer Incidence and Mortality in the United States 1973—1976. Edited by JL Young Jr, AJ Asire, ES Pollack. DHEW Publication No NIH 78-1837, Bethesda, MD, 1978
3. Burdick D: Rehabilitation of the breast cancer patient. Cancer 36:645-648, 1975
4. Zdeb MS: The probability of developing cancer. Am J Epidemiol 106:6-16, 1977
5. Wigle DT: Breast cancer and fertility trends in Canada. Am J Epidemiol 105:428-438, 1977
6. Connecticut Tumor Registry: Unpublished data, 1979
7. Armstrong B: Recent trends in breast-cancer incidence and mortality in relation to changes in possible risk factors. Int J Cancer 17:204-211, 1976
8. Holford TR: Unpublished data, 1979
9. Devesa SA, Silverman DT: Cancer incidence and mortality trends in the United States: 1935-74. J Natl Cancer Inst 60:545 — 571, 1978
10. Urban JA: Changing patterns of breast cancer. Cancer 37:111-117, 1976
11. Feinleib M, Garrison RJ: Interpretation of the vital statistics of breast cancer. Cancer 24: 1109-1116, 1969
12. Anderson E, Reed SC, Huseby RA, et al: Possible relationship between menopause and age at onset of breast cancer. Cancer 3:410-414, 1950
13. Clemmensen J: Statistical studies in the aetiology of malignant neoplasms. I. Review and results. Acta Pathol Microbiol Scand 174 (Suppl):1-543, 1965
14. Lilienfeld AM, Johnson EA: The age distribution in female breast and genital cancers. Cancer 8:875-882, 1955
15. Lee JAH, Chin PG, Kukull WA, et al: Relationship of age to incidence of breast cancer in young women. J Natl Cancer Inst 57: 753-756, 1976
16. Wynder EL, Bross JJ, Hirayama T: A study of the epidemiology of cancer of the breast. Cancer 13:559-601, 1960
17. The Third National Cancer Survey: Incidence Data. National Cancer Institute Monograph 41, DHEW Publication No NIH 75-787, Bethesda, 1975
18. Salber EJ, Trichopoulos D, MacMahon B: Lactation and reproductive histories of breast cancer patients in Boston 1965—66. J Natl Cancer Inst 43:1013-1024, 1969
19. Dunham LJ, Bailar JC HI, Laqueur GL: Histologically diagnosed cancers in 693 Indians of the United States, 1950-65. J Natl Cancer Inst 50:1119-1127, 1973
20. Menck HR, Henderson BE, Pike MC, et al: Cancer incidence in the Mexican-American. J Natl Cancer Inst 55:531-536, 1975
21. Cohart E: Socioeconomic distribution of cancer of the female sex organs in New Haven. Cancer 8:34- 41, 1955
22. Graham S, Levin M, Lilienfeld AM: The socioeconomic distribution of cancer of various sites in Buffalo, NY, 1948-1952. Cancer 13: 180-191, 1960
23. Schwartz D, Denoix PF, Rouquette C: Enquête sur l’étiologie des cancers genetaux de la femme. I. Cancer Dusein. Bull Assoc Franc etude Cancer 45:476-493, 1958
24. Valaoras VG, MacMahon B, Trichopoulos D, et al: Lactation and reproductive histories of breast cancer patients in greater Athens, 1965—67. Int J Cancer 4:350-363, 1969
25. Lowe CR, MacMahon B: Breast cancer and reproductive history of women in South Wales. Lancet 1:153-157, 1970
26. Fasal E, Paffenbarger RS: Oral contraceptives as related to cancer and benign lesions of the breast. J Natl Cancer Inst 55:767-773, 1975
27. Mustacchi P: Ramizzini and Rigoni-Stem: Parity and breast cancer. Arch Intern Med 108: 639-642, 1961
28. Damon E: Host factors in cancer of the breast and uterine cervix and corpus. J Natl Cancer Inst 24:483-516, 1960
29. Graham JB: Characteristics of women with various gynecologic cancers. Obstet Gynecol 23:176-181, 1964
30. Lilienfeld AM: The relationship of cancer of the female breast to artificial menopause and marital status. Cancer 9:927-934, 1956
31. Lilienfeld AM: Epidemiologic concepts applied to studies of chronic diseases. In Genetics and the Epidemiology of Chronic Diseases. Edited by JV Neil, M Shaw, WJ Schull. PHS Publication No 1163, 1965
32. Logan WP: Marriage and childbearing in relation to cancer of the breast and uterus. Lancet 2:1199-1202, 1953
33. MacMahon B, Feinleib M: Breast cancer in relation to nursing and menopausal history. J Natl Cancer Inst 24:733-753, 1960
34. Shapiro S, Strax P, Venet L, et al: The search for risk factors in breast cancer. Am J Public Health 58:820-835, 1968
35. MacMahon B, Cole P, Lin TM, et al: Age at first birth and breast cancer risk. Bull WHO 43:209-221, 1970
36. MacMahon B, Lin TM, Lowe CR, et al: Lactation and cancer of the breast. A Summary of an International Study. Bull WHO 42:185-194, 1970
37. Yuasa S, MacMahon B: Lactation and reproductive histories of breast cancer patients in Tokyo, Japan. Bull WHO 42:195-204, 1970
38. Lin TM, Chen KP, MacMahon B: Epidemiologic characteristics of cancer of the breast in Taiwan. Cancer 27:1497-1504, 1971
39. Mirra AP, Cole P, MacMahon B: Breast cancer in an area of high parity. Sao Paulo, Brazil. Cancer Res 31:77-83, 1971
40. Ravnihar B, MacMahon B, Lindtner, J: Epidemiologic features of breast cancer in Slovenia, 1965-67. Eur J Cancer 7:295-306, 1971
41. Sartwell PE, Arthes FG, Tonascia JA: Benign and malignant breast tumours: Epidemiological similarities. Int J Epidemiol 7:217-221, 1978
42. Sartwell PE, Arthes FG, Tonascia JA: Exogenous hormones, reproductive history, and breast cancer. J Natl Cancer Inst 59:1589-1592, 1977
43. Brinton LA, Williams RR, Hoover RN, et al: Breast cancer risk factors among screening program participants. J Natl Cancer Inst 62:37-44, 1979
44. Fraumeni JF Jr., Lloyd JW, Smith EM, et al: Cancer mortality among nuns: Role of marital status in etiology of neoplastic disease in women. J Natl Cancer Inst 42:455-468, 1969
45. Blot WJ, Fraumeni JF Jr., Stone BJ: Geographic patterns of breast cancer in the United States. J Natl Cancer Inst 59:1407-1411, 1977
46. Doll R, Payne P, Waterhouse J (eds): Cancer Incidence in Five Continents. Berlin, Heidelberg, New York, Springer-Verlag, 1966
47. DeWaard F: The epidemiology of breast cancer: Review and prospects. Int J Cancer 4:577-586, 1969
48. Clemmensen J: Carcinoma of the breast: Results from statistical research. Br J Radiol 21:583 -590, 1948
49. Bjamason O, Day N, Snaedal G, et al: The effect of year of birth on the breast cancer age-incidence curve in Iceland. Int J Cancer 13:689-696, 1974
50. DeWaard F, Comelis JP, Aoki K, et al: Breast cancer incidence according to weight and height in two cities of the Netherlands and in Aichi Prefective, Japan. Cancer 40:1269-1275, 1977
51. Modan B, Bareli V, Lubin F, et al: Dietary factors and cancer in Israel. Cancer Res 35: 3503-3506, 1975
52. Buell P: Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 51:1479-1483, 1973
53. Haenszel W, Kurihara M: Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40:43-68, 1968
54. Morrison AS, Black MM, Lowe CR, et al: Some international differences in histology and survival in breast cancer. Int J Cancer 11:261-267, 1973
55. Chabon AB, Takeuchi S, Sommers SC: Histological differences in breast carcinoma of Japanese and American women. Cancer 33: 1577-1579, 1974
56. MacMahon B, Morrison AS, Ackerman LV, et al: Histologic characteristics of breast cancer in Boston and Tokyo. Int J Cancer 11:338-344, 1973
57. Wynder EL, Kajitani T, Kuno J, et al: A comparison of survival rates between American and Japanese patients with breast cancer. Surg Gynecol Obstet 117:196-200, 1963
58. Rosen PP, Ashikari R, Thaler H, et al: A comparative study of some pathologic features of mammary carcinoma in Tokyo, Japan and New York, USA. Cancer 39:429-434, 1977
59. Nemoto T, Tominaga T, Chamberlain A, et al: Differences in breast cancer between Japan and the United States. J Natl Cancer Inst 58:193-197, 1977
60. Morrison AS, Lowe CR, MacMahon B, et al: Survival of breast cancer patients related to incidence risk factors. Int J Cancer 9:470-476, 1972
61. Blot WJ, Fraumeni JF Jr., Young JL Jr.: Leftsided breast cancer. Lancet 2:762-763, 1977
62. Garfinkel L, Craig L, Seidman H: An appraisal of left and right breast cancer. J Natl Cancer Inst 23:617-631, 1959
63. McManus IC: Predominance of left-sided breast tumours. Lancet 2:297-298, 1977
64. Busk R, Clemmensen J: Frequencies of left and right-sided breast cancer. Br J Cancer 1:345-351, 1947
65. Fisher ER, Gregorio RM, Fisher B: The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Breast Project (Protocol No 4). Cancer 36:1-85, 1975
66. Dorn HF, Cutler SJ: Morbidity from cancer in the United States. I. Variation in incidence by age, sex, race, marital status, and geographic region. Public Health Monograph No 29. Washington DC, US GPO, 1955
67. Ing R, Ho JHC, Petrakis NL: Unilateral breast-feeding and breast cancer. Lancet 2:124-127, 1977
68. Craig TJ, Comstock GW, Geiser PB: Epidemiologic comparison of breast cancer patients with early and late onset of malignancy and general population controls. J Natl Cancer Inst 53:1577-1581, 1974
69. Lilienfeld AM, Coombs J, Bross IDJ, et al: Marital and reproductive experience in a community-wide epidemiological study of breast cancer. Johns Hopkins Med J 136: 157-162, 1975
70. Henderson BE, Powell D, Rosario I, et al: An epidemiologic study of breast cancer. J Natl Cancer Inst 53:609-614, 1974
71. Tulinius H, Day NE, Johannesson G, et al: Reproductive factors and risk for breast cancer in Iceland. Int J Cancer 21:724-730, 1978
72. Thein-Hlang, Thein Maung-Myint: Risk factors of breast cancer in Burma. Int J Cancer 21:432-437, 1978
73. Choi NW, Howe GR, Miller AB, et al: An epidemiologic study of breast cancer. Am J Epidemiol 107:510-521, 1978
74. Adami HO, Rimsten A, Stenkvist B, et al: Reproductive history and breast cancer. Cancer 41:747-757, 1978
75. Morrison AS: Histologic specificity of the effect of age at birth of first child on breast cancer risk. Int J Cancer 18:723-726, 1976
76. Sherman BM, Korenman SG: Inadequate corpus luteum function: A pathophysiological interpretation of human breast cancer epidemiology. Cancer 33:1306-1312, 1974
77. Grattarola R: The premenstrual endometrial pattern of women with breast cancer. Cancer 17:1119-1122, 1964
78. Swain MC, Bulbrook RD, Hayward JL: Ovulatory failure in a normal population and in patients with breast cancer. J Obstet Gynecol Br Commonwealth 81:640-643, 1974
79. Wainright JM: A comparison of conditions as sociated with breast cancers in Great Britain and America. Am J Cancer 15:2610-2645, 1931
80. Stavraky K, Emmons S: Breast cancer in premenopausal and postmenopausal women. J Natl Cancer Inst 53:647-654, 1974
81. Kaplan SD, Acheson RM: A single etiological hypothesis for breast cancer? J Chron Dis 19:1221-1230, 1966
82. Herrell WE: The relative incidence of oophorectomy in women with and without carcinoma of the breast. Am J Cancer 29:659-665, 1937
83. Trichopoulos D, MacMahon B, Cole P: Menopause and breast cancer risk. J Natl Cancer Inst 48:605-613, 1972
84. Feinleib M: Breast cancer and artificial menopause: A cohort study. J Natl Cancer Inst 41:315-329, 1968
85. Hirayama T, Wynder EL: A study of the epidemiology of cancer of the breast. II. The influence of hysterectomy. Cancer 15:28-38, 1962
86. Schneider R, Dorn CR, Taylor DON: Factors influencing canine mammary cancer development and post-surgical survival. J Natl Cancer Inst 43:1249-1261, 1969
87. Staszewski J: Age at menarche and breast cancer. J Natl Cancer Inst 47:935-940, 1971
88. Herity BA, O’halloran MJ, Bourke GJ, et al: A study of breast cancer in Irish women. Br J Prev Soc Med 29:178-181, 1975
89. Standfast SJ: Birth characteristics of women dying from breast cancer. J Natl Cancer Inst 39:33-42, 1967
90. Kodlin D, Winger EE, Morgenstern NL, et al: Chronic mastopathy and breast cancer. A follow-up study. Cancer 39:2603-2607, 1977
91. Donnelly PK, Baker KW, Carney JA, et al: Benign breast lesions and subsequent breast carcinoma in Rochester, Minnesota. Mayo Clin Proc 50:650-656, 1975
92. Haagensen CD: Diseases of the breast. Second edition. Philadelphia, PA, WB Saunders, 1971
93. Haagensen CD: The relationship of gross cystic disease of the breast and carcinoma. Ann Surg 185:375-376, 1977
94. Mohson RR, Yen S, MacMahon B, et al: Chronic mastitis and carcinoma of the breast. Lancet 2:224-226, 1976
95. Davis HH, Simons M, Davis JB: Cystic disease of the breast: Relationship to carcinoma. Cancer 17:957-978, 1964
96. Warren S: The relation of "chronic mastitis” to carcinoma of the breast. Surg Gynecol Obstet 71:257- 273, 1940
97. Potter JF, Slimbaugh WP, Woodward SC: Can breast carcinoma be anticipated? A follow-up of benign breast biopsies. Ann Surg 167: 829-838, 1968
98. Lewison EF, Lyons JG: Relationship between benign breast disease and cancer. Arch Surg 66:94-110, 1953
99. Devitt JE: Breast cancer and preceding clinical benign breast disorders. A chance association. Lancet 1:793-795, 1976
100. Devitt JE: Fibrocystic disease of the breast is not premalignant. Surg Gynecol Obstet 134: 803-806, 1972
101. Macgillivray JB: The problem of "chronic mastitis” with epitheliosis. J Clin Pathol 22: 340-347, 1969
102. Ackerman LV, Katzenstein AL: The concept of minimal breast cancer and the pathologist’s role in the diagnosis of "early carcinoma.” Cancer 39:2755-2763, 1977
103. Haagensen CD, Lane N, Lattes R, et al: Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737-769, 1978
104. Humphrey LJ, Swerdlow MA: Large duct epithelial hyperplasia and carcinoma of the breast. Arch Surg 97:592-594, 1968
105. McDivitt RW, Hutter RV, Foote FW Jr., et al: In situ lobular carcinoma. A prospective follow-up study indicating cumulative patient risks. JAMA 201:96-102, 1967
106. Black MM, Chabon AB: In situ carcinoma of the breast. Pathol Annu 4:185-210, 1969
107. Black MM, Barclay THC, Cutler SJ, et al: Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer. Cancer 29:338-343, 1972
108. Page BL, Vander Zwaag R, Rogers LW, et al: Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 61:1055-1063, 1978
109. LiVolsi VA, Stadel BV, Kelsey JL, et al: Fibrocystic breast disease in oral contraceptive users: A histopathologic evaluation of epithelial atypia. N Engl J Med 299:381-385, 1978
110. Kelsey JL: Unpublished data, 1979
111. Frantz VK, Pickren JW, Melcher GW, et al: Incidence of chronic cystic disease in so-called "normal breasts”: A study based on 225 postmortem examinations. Cancer 4:762-783, 1951
112. Sloss PT, Bennett WA, Clagett OT: Incidence in normal breasts of features associated with chronic cystic mastitis. Am J Pathol 33: 1181-1191, 1957
113. Kelsey JL, Lindfors KK, White C: A case-control study of the epidemiology of benign breast diseases with reference to oral contraceptive use. Int J Epidemiol 3:333-340, 1974
114. Nomura A, Comstock GW, Tonascia JA: Epidemiologic characteristics of benign breast disease. Am J Epidemiol 105:505-512, 1977
115. Cole P, Elwood JM, Kaplan SD: Incidence rates and risk factors of benign breast neoplasms. Am J Epidemiol 108:112-120, 1978
116. Sartwell PE, Arthes FG, Tonascia JA: Epidemiology of benign breast lesions: Lack of associations with oral contraceptive use. N Engl J Med 288:551-554, 1973
117. Ory H, Cole P, MacMahon B, et al: Oral contraceptives and reduced risk of benign breast diseases. N Engl J Med 294:419-422, 1976
118. Vessey MP, Doll R, Sutton PM: Oral contraceptives and breast neoplasia: A retrospective study. Br Med J 3:719-724, 1972
119. Schoenberg BS: Multiple Primary Malignant Neoplasms: The Connecticut Experience, 1935-1964. New York, Springer-Verlag, 1977
120. Schottenfeld D, Berg J: Incidence of multiple primary cancers. IV. Cancers of the female breast and genital organs. J Natl Cancer Inst 46:161-170, 1971
121. Robbin, B GF, Berg JW: Bilateral primary breast cancers: A prospective clinicopathologi-cal study. Cancer 17:1501-1527, 1964
122. Schottenfeld D, Berg J: Epidemiology of multiple primary cancers. In Cancer Epidemiology and Prevention. Current Concepts. Edited by D. Schottenfeld. Springfield, IL, Charles C Thomas, 1975, pp 416-434
123. Bordin GM, Key CR, McQuade CE, et al: Multiple primary cancers. Relative risk in New Mexico’s triethnic population. Cancer 40: 1793-1800, 1977
124. Newell GR, Rawlings W, Krementz ET, et al: Multiple primary neoplasms in blacks compared to whites. III. Initial cancers of the female breast and uterus. J Natl Cancer Inst 53:369-373, 1974
125. Lewison EF, Neto AS: Bilateral breast cancer at the Johns Hopkins Hospital. Cancer 28: 1297-1301, 1971
126. Anderson DE: Some characteristics of familial breast cancer. Cancer 28:1500-1504, 1971
127. Schoenberg BS, Greenberg RA, Eisenberg H: Occurrence of certain multiple primary cancers in females. J Natl Cancer Inst 43:15-32, 1969
128. Reemer RR, Hoover R, Fraumeni JF Jr., et al: Second primary neoplasms following ovarian cancer. J Natl Cancer Inst 61:1195-1197, 1978
129. MacMahon B, Austin JH: Association of carcinomas of the breast and corpus uteri. Cancer 23:275-280, 1969
130. Vongtama V, Kurohara SS, Badib AO, et al: Second primary cancers of endometrial carcinoma. Cancer 26:842-846, 1970
131. Bailar JC HI: The incidence of independent tumors among uterine cancer patients. Cancer 16:842-853, 1963
132. Schoenberg BS, Christine BW: Multiple primary malignancies: Index tumors of the breast and reproductive organs. Excerpta Medica International Congress Series No 351. Vol 3. Cancer Epidemiology, Environmental Factors. Proceedings of the Xlth International Cancer Congress, Florence, Italy, 1974
133. Schottenfeld D, Berg JW, Vitsky B: Incidence of multiple primary cancers. II. Index cancers arising in the stomach and lower digestive system. J Natl Cancer Inst 43:79- 86, 1969
134. Schoenberg BS, Christine BW: The association of neoplasms of the colon and rectum with primary malignancies of other sites. Am J Proctol 4:41-58, 1974
135. Lemon HM: Experimental basis for multiple primary carcinogenesis by sex hormones Cancer 40:1825-1832, 1977
136. Wynder EL, Hyams L, Shijematsu T: Correlation of international cancer death rates. Cancer 20:113-126, 1967
137. Burbank F: A sequential space-time cluster analysis of cancer mortality in the United States: Etiologie implications. Am J Epidemiol95:393-417, 1972
138. Schoenberg BS: Multiple primary neoplasms. In Persons at High Risk of Cancer. Edited by JF Fraumeni Jr. New York, Academic Press, 1975
139. Carey RW, Holland JF, Sheehe PR, et al: Association of cancer of the breast and acute myelocytic leukemia. Cancer 20:1081-1088, 1967
140. Dunn JE, Bragg KU, Saulter C, et al: Breast cancer risk following mqjor salivary gland carcinoma. Cancer 29:1343-1346, 1972
141. Berg J, Hutter RVP, Foote FW Jr.: The unique association between salivary gland cancer and breast cancer. JAMA 204:771-774, 1968
142. Schoenberg BS: Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer. Neurology 25:705-712, 1975
143. Lynch HT, Krush AJ: Carcinoma of the breast and ovary in three families. Surg Gynecol Obstet 133:644-648, 1971
144. Li FP, Fraumeni JF Jr.: Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 71:747-752, 1969
145. Smith FP, Slavik M, MacDonald JS: Association of breast cancer with meningioma. Cancer 42:1992-1994, 1978
146. Anderson DE: A genetic study of human breast cancer. J Natl Cancer Inst 48:1029-1034, 1972
147. Tokuhata GK: Morbidity and mortality among offspring of breast cancer mothers. Am J Epidemiol 89:139-153, 1969
148. Macklin MT: Comparison of the number of breast-cancer deaths observed in relatives of breast-cancer patients, and the number expected on the basis of mortality rates. J Natl Cancer Inst 22:927-951, 1959
149. Post RH: Breast cancer, lactation, and genetics. Eugen Q 13:1-29, 1966
150. Lilienfeld AM: The epidemiology of breast cancer. Cancer Res 23:1503-1513, 1963
151. Lynch HI, Krush AJ: Genetic predictability in breast cancer risk. Arch Surg 103:84-88, 1971
152. Cady B: Familial bilateral cancer of the breast. Ann Surg 172:264-272, 1970
153. Finney GG Jr., Finney GG, Montague ACW, et al: Bilateral breast cancer, clinical and pathological review. Ann Surg 175:635-646, 1972
154. Anderson DE: Breast cancer in families. Cancer 40:1855-1860, 1977
155. Anderson DE: Genetic study of breast cancer: Identification of a high risk group. Cancer 34:1090-1097, 1974
156. Lynch HT, Harris RE, Guirgis HA, et al: Familial association of breast/ovarian carcinoma. Cancer 41:1543-1549, 1978
157. Fraumeni JF Jr., Grundy GW, Creagan ET, et al: Six families prone to ovarian cancer. Cancer 36:364-369, 1975
158. Lynch HT, Guirgis HA, Albert S, et al: Familial association of carcinoma of the breast and ovary. Surg Gynecol Obstet 138:717-724, 1974
159. Lynch HT, Krush AJ, Guirgis H: Genetic factors in families with combined gastrointestinal and breast cancer. Am J Gastroenterol 59: 31-40, 1973
160. Lynch HT, Krush AJ, Harlan WL, et al: Association of soft tissue sarcoma, leukemia and brain tumors in families affected with breast cancer. Am Surg 39:199-206, 1973
161. Lynch HT, Krush AJ, Lemon HM, et al: Tumor variation in families with breast cancer. JAMA 222:1631-1639, 1972
162. Petrakis NL: Cerumen genetics and human breast cancer. Science 173:347-349, 1971
163. Ing R, Petrakis NL, Ho HC: Evidence against association between wet cerumen and breast cancer. Lancet 1:41, 1973
164. Boston Collaborative Drug Surveillance Programme: Relation between breast cancer and S blood-antigen system. Lancet 1:301-305, 1971
165. Morosini P, Lee EG, Jones MN, et al: Breast cancer and the S blood-group system. Lancet 1:411-412, 1972
166. Patel R, Habal MB, Wilson RE, et al: Histocompatibility (HL-A) antigens and cancer of the breast. Am J Surg 124:31-34, 1972
167. Cordon AL, James DCO: HL-A carcinoma of the breast. Lancet 2:565, 1973
168. De Jong-Bakker M, Cleton FJ, D’amaro J, et al: HL-A antigens and breast cancer. Eur J Cancer 10:555-558, 1974
169. Martz E, Benacerraf B: Lack of association between carcinoma of the breast and HL-A specificities. Tissue Antigens 3:30-38, 1973
170. Petrakis NL: Genetic factors in the etiology of breast cancer. Cancer 39:2709-2715, 1977
171. Kirschner MA: The role of hormones in the etiology of human breast cancer. Cancer 39:2716-2726, 1977
172. MacMahon B, Cole P: The ovarian etiology of human breast cancer. In Current Problems in the Epidemiology of Cancer and Lymphomas. Edited by E Grundmann, H Tulinius. New York, Springer-Verlag, 1972
173. Cole P, MacMahon B: Oestrogen fractions during early reproductive life in the aetiology of breast cancer. Lancet 1:604-606, 1969
174. Lemon HM, Wotiz HH, Parsons L, et al: Reduced estriol excretion in patients with breast. cancer prior to endocrine therapy. JAMA 196:1128-1136, 1966
175. MacMahon B, Cole P, Brown J, et al: Oestrogen profiles of Asian and North American women. Lancet 2:900-902, 1971
176. MacMahon B, Cole P, Brown JB, et al: Estrogen profiles of Asian and North American women. Int J Cancer 14:161-167, 1974
177. Dickinson LE, MacMahon B, Cole P, et al: Estrogen profiles of oriental and Caucasian women in Hawaii. N Engl J Med 291:1211-1213, 1974
178. Gross J, Modan B, Bertini B, et al: Relationship between steroid excretion patterns and breast cancer incidence in Israeli women of various origins. J Natl Cancer Inst 59:7-11, 1977
179. Briggs M: Ethnic differences in urinary oestro-gens. Lancet 1:324, 1972
180. Bulbrook RD, Swain MC, Wang DY, et al: Breast cancer in Britain and Japan: Plasma oestradiol-17B, oestrone and progesterone, and their urinary metabolites in normal British and Japanese women. Eur J Cancer 12:725-735, 1976
181. Cole P, Brown JB, MacMahon B: Oestrogen profiles of parous and nulliparous women. Lancet 2:596-599, 1976
182. Morgan RW, Vakil DV, Brown JB, et al: Estrogen profiles in young women: Effect of maternal history of breast cancer. J Natl Cancer Inst 60:965-968, 1978
183. Pike MC, Casagrande JT, Brown JB, et al: Comparison of urinary and plasma hormone levels in daughters of breast cancer patients and controls. J Natl Cancer Inst 59:1351-1356, 1977
184. Fishman J, Fukushima D, O’Connor J, et al: Plasma hormone profiles of young women at risk for familial breast cancer. Cancer Res 38:4006-4011, 1978
185. Lipsett MB: Oestrogen profiles and breast cancer. Lancet 2:1378, 1971
186. Longcope C, Pratt JH: Relationship between urine and plasma estrogen ratios. Cancer Res 38:4025-4028, 1978
187. Deshpande N, Carson P, Horner J: Oestriol in human breast tumours. J Steroid Biochem 7:11-13, 1976
188. Anderson JN, Peck EJ, Clark JH: Estrogen-induced uterine responses and growth: Relationship to receptor estrogen binding by uterine necks. Endocrinology 96:160-167, 1975
189. Martin L, Pollard JW, Fagg B: Oestriol, oestradiol-17B and the proliferation and death of uterine cells. J Endocrinol 69:103-115, 1976
190. Clark JH, Paszko Z, Peck EJ: Nuclear bending and retention of the receptor estrogen complex: Relation to the agonistic and antagonistic properties of estriol. Endocrinology 100:91-96, 1977
191. Rudali G, Apiou F, Muel B: Mammary cancer produced in mice with oestriol. Eur J Cancer 2:39-48, 1975
192. Brown JB: The determination of the significance of natural estrogens. Adv Clin Chem 3:157-233, 1960
193. Zumoff B, Fishman J, Bradlow HJ, et al: Hormone profiles in hormone-dependent cancers. Cancer Res 35:3365-3372, 1975
194. Martucci C, Fishman J: Direction of estradiol metabolism as a control of its hormone action: Uterotrophic activity of estradiol metabolites. Endocrinology 101:1709-1715, 1977
195. Wotiz HH, Chattoraj SC, Kudisch M, et al: Impeding estrogen and the etiology of breast cancer. Cancer Res 38:4012-4020, 1978
196. Lemon HM: Estriol prevention of mammary carcinoma induced by 7, 12-dimethyl-benz-anthracene and procarbazine. Cancer Res 35:1341-1353, 1975
197. Tseng L, Guipide E: Nuclear concentration of estriol in supervised human endometrium: Competition with estradiol. J Steroid Biochem 5:273-278, 1974
198. Cole P, Cramer D, Yen S, et al: Estrogen profiles of premenopausal women with breast cancer. Cancer Res 38:745-748, 1978
199. Arguelles AE, Poggi UL, Saborida C, et al: Endocrine profiles and breast cancer. Lancet 1:165-168, 1973
200. England PC, Skinner LG, Cottrell KM, et al: Serum oestradiol-17B in women with benign and malignant breast disease. Br J Cancer 30:571-576, 1974
201. Pratt JH, Longcope C: Estriol production rates and breast cancer. J Clin Endocrinol Metab 46:44-47, 1978
202. Longcope C, Pratt JH: Blood production rates of estrogen in women with differing ratios of urinary estrogen conjugation. Steroids 29: 483 -492, 1977
203. Rader MD, Flickinger DL, de Villa GU Jr., et al: Plasma estrogens in postmenopausal women. Am J Obstet Gynecol 116:1069-1073, 1973
204. Schindler AE, Ebert A, Friedrich E: Conversion of androstenedione to estrone by human fat tissue. J Clin Endocrinol Metab 35: 627-630, 1972
205. Siiteri PK, Schwarz BE, MacDonald PC: Estrogen receptors and the estrone hypothesis in relation to endometrial and breast cancer. Gynecol Oncol 2:228-238, 1974
206. Grodin JM, Siiteri PK, MacDonald PC: Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 36:207-214, 1973
207. Kirschner MA, Cohen FB, Ryan C: Androgenestrogen production rates in postmenopausal women with breast cancer. Cancer Res 38: 4029-4035, 1978
208. Mahlbock M, Boot LM: The mode of action of ovarian hormones in the induction of mammary cancer in mice. Biochem Pharmacol 16: 627-630, 1967
209. Poel WE: Progesterone enhancement of mammary development as a causal model of cocarcinogenesis. Br J Cancer 22:867-873, 1968
210. Sherman BM, Korenman SG: Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 55:699-706, 1975
211. Sherman BM, West JH, Korenman SG: The menopausal transition: Analysis of LH, FSH, estradiol and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 42:629-636, 1976
212. Welsch CW, Nagasawa H: Prolactin and murine mammary tumorigenesis: A review. Cancer Res 37:951-963, 1977
213. Sasaki GH, Leung BS: On the mechanism of action of hormone action in 7, 12-dimethyl-benz(a)anthracene-induced mammary tumor. Cancer 35:645-651, 1975
214. Sinha D, Cooper D, Dao TL: The nature of es. trogen and prolactin effect on mammarytumorigenesis. Cancer Res 33:411-414, 1973
215. Franks S, Ralphs DNL, Seagroatt V, et al: Prolactin concentrations in patients with reast cancer. Br Med J 4:320-321, 1974
216. Boyns AR, Cole EN, Griffiths K, et al: Plasma prolactin in breast cancer. Eur J Cancer 9:99-102, 1973
217. Mittra I, Hayward JL, McNeilly AS: Hypothalmic-pituitary-thyroid axis in breast cancer. Lancet 1:885-888, 1974
218. Mittra I, Hayward JL: Hypothalmic-pituitary-prolactin axis in breast cancer. Lancet 1:889-891, 1974
219. Murray RML, Mozaffarian G, Pearson OH: Prolactin levels with L-dopa treatment in metastatic breast carcinoma. In Prolactin and Carcinogenesis. Edited by AR Boyns, K Griffiths. Alpha Omega Alpha, Cardiff, 1972, p 158
220. Roland E, Barreca T, Masturzo P, et al: Plasma prolactin in breast cancer. Lancet 2:845-846, 1974
221. Henderson BE, Gerkins V, Rosario I, et al: Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer. N Engl J Med 293:790-795, 1975
222. Kwa HG, Clefton F, de Jong-Bakker M, et al: Plasma prolactin and its relationship to risk factors in human breast cancer. Int J Cancer 17:441-447, 1976
223. Kumaoka S, Takatami O, Abe O, et al: Plasma prolactin, thyroid-stimulating hormone, follicle-stimulating hormone and luteinizing hormone in normal British and Japanese women. Eur J Cancer 12:767-774, 1976
224. Hill P, Wynder EL, Kumar J, et al: Prolactin levels in populations at risk for breast cancer. Cancer Res 36:4102-4106, 1976
225. Bulbrook RD, Hayward JL, Spicer CC: Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet 2:395-398, 1971
226. Bulbrook RD, Hayward JL: Abnormal urinary steroid excretion and subsequent breast cancer. A prospective study in the Island of Guernsey. Lancet 1:519-522, 1967
227. Grattarola R: Androgens in breast cancer. I. Atypical endometrial hyperplasia and breast cancer in married premenopausal women. Am J Obstet Gynecol 116:423-428, 1973
228. Bulbrook RD, Thomas BS: Urinary 11-deoxy-17-oxosteroids in British and Japanese women with reference to the incidence of breast cancer. Nature 201:189-190, 1964
229. Bulbrook RD: Some basic difficulties in attempting to predict response to therapy by endocrine assays. Natl Cancer Inst Monograph No 34:39-41, 1971
230. Bogardus GM, Finley JW: Breast cancer and thyroid disease. Surgery 49:461-468, 1961
231. Backwinkel K, Jackson AS: Some features of breast cancer and thyroid deficiency. Cancer 17:1174-1176, 1964
232. Humphrey LJ, Swerdlow M: The relationship of breast disease to thyroid disease. Cancer 17:1170-1173, 1964
233. Royal College of General Practitioners: Oral contraceptives and health. New York, Pitman, 1974
234. Vessey MP, Doll R, Peto R, et al: A long-term follow-up study of women using different methods of contraception—An interim report. J Biosoc Sei 8:373-427, 1976
235. Vessey MP, Doll R, Jones K: Oral contraceptives and breast cancer. Lancet 1:941-944, 1975
236. Kelsey JL, Holford TR, White C, et al: Oral contraceptives and breast disease: An epidemiological study. Am J Epidemiol 107:236-244, 1978
237. Arthes FG, Sartwell PE, Lewison EF: The pill, estrogens, and the breast. Epidemiologic aspects. Cancer 28:1391-1394, 1971
238. Paffenbarger RS, Fasal E, Simmons ME, et al: Cancer risk as related to use of oral contraceptives during fertile years. Cancer 39 (Suppl):1887-1891, 1977
239. Boston Collaborative Drug Surveillance Program: Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Lancet 1:1399-1404, 1973
240. Nomura A, Comstock GW: Benign breast tumor and estrogenic hormones: A population-based retrospective study. Am J Epidemiol 103:439-444, 1976
241. Royal College of General Practitioners: Oral contraceptive study: Effect on hypertension and benign breast disease of progestagen component in combined oral contraceptives. Lancet 1:624, 1977
242. McLaughlin CW, Schenken JR, Tamisiea JX: A study of precancerous epithelial hyperplasia and noninvasive papillary carcinoma of the breast. Ann Surg 153:735-744, 1961
243. Greene RR, Brewer JI: Relation of sex hormones to tumors of the female reproductive system. AJR 45:426-445, 1941
244. Wallach S, Henneman PH: Prolonged estrogen therapy in postmenopausal women. JAMA 171:1637-1642, 1959
245. Burch JC, Byrd BF Jr: Effects of long-term administration of estrogen in the occurrence of mammary cancer in women. Ann Surg 174: 414-418, 1971
246. Wilson RA: The roles of estrogen and progesterone in breast and genital cancer. JAMA 182:327-331, 1962
247. Burch JC, Byrd BF Jr, Vaughn WK: The effects of long-term estrogen on hysterectomized women. Am J Obstet Gynecol 118:778-782, 1974
248. Casagrande J, Gerkins V, Henderson BE, et al: Exogenous estrogens and breast cancer in women with natural menopause. J Natl Cancer Inst 56:839-841, 1976
249. Hoover R, Gray LW Sr, Cole P, et al: Menopausal estrogens and breast cancer. N Engl J Med 295:401-405, 1976
250. Bibbo M, Haenszel WM, Wied GL, et al: A twenty-five year follow-up study of women exposed to diethylstilbestrol during pregnancy. N Engl J Med 298:763-767, 1978
251. Kapde CC, Wolfe JN: Breast cancer: Relationship to thyroid supplements for hypothyroidism. JAMA 236:1124-1127, 1976
252. Wallace RB, Sherman BM, Bean JA, et al: Thyroid hormone use in patients with breast cancer. Absence of an association. JAMA 239:958, 1978
253. Mustacchi P, Greenspan F: Thyroid supplementation for hypothyroidism: An iatrogenic cause of breast cancer? JAMA 237: 1446-1447, 1977
254. Carroll KK: Experimental evidence of dietary factors and hormone dependent cancers. Cancer Res 35:3374-3383, 1975
255. Chan P, Cohen LA: Effect of dietary fat, antiestrogen and antiprolactin on the development of mammary tumours in rats. J Natl Cancer Inst 52:24-30, 1974
256. Tannenbaum A: The genesis and growth of tumors, in. Effects of a high fat diet. Cancer Res 2:468-475, 1942
257. Carroll KK, Khor HT: Effects of dietary fat and dose level of 7, 12-dimethylbenz(a)anthracene in mammary tumor incidence in rats. Cancer Res 30:2260-2264, 1970
258. Chan PC, Cohen LA, Wynder EL: Increased yield of N-nitrosomethylurea-induced mammary tumors by dietary fat. Proc Am Assoc Cancer Res 17:133, 1976
259. Gammal EB, Carroll KK, Plunkett ER: Effects of dietary fat on mammary carcinogenesis by 7, 12-dimethylbenz(a)anthracene in rats. Cancer Res 27:1737-1742, 1967
260. Dunning WF, Curtis MR, Maun ME: The effect of dietary fat and carbohydrate on diethylstil-bestrol-induced mammary cancer in rats. Cancer Res 9:354-361, 1949
261. Engel RW, Copeland DH: Influence of diet on the relative incidence of eye, mammary, ear-duct and liver tumors in rats fed 2-ace-tylaminofluorene. Cancer Res 11:180—183, 1951
262. Carroll KK, Khor HT: Effects of level and type of dietary fat on incidence of mammary tumours induced in female Sprague-Dawley rats by 7, 12-dimethylbenzanthracene. Lipids 6:415-420, 1971
263. Silverstone H, Tannenbaum A: The effect of the proportion of dietary fat on the rate of formation of mammary carcinoma in mice. Cancer Res 10:448-453, 1950
264. Benson J, Lev M, Grand CG: Enhancement of mammary fibroadenomas in the female rat by a high fat diet. Cancer Res 16:135-137, 1956
265. Lea AJ: Dietary factors associated with death-rates from certain neoplasms in man. Lancet 2:332-333, 1966
266. Carroll KK, Gammel EB, Plunkett ER: Dietary fat and mammary cancer. Can Med Assoc J 98:590-594, 1968
267. Armstrong B, Doll R: Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices. Int J Cancer 15:617—631, 1975
268. Hems G: Epidemiological characteristics of breast cancer in middle and late age. Br J Cancer 24:226-234, 1970
269. Drasar BS, Irving D: Environmental factors and cancer of the colon and breast. Br J Cancer 27:167-172, 1973
270. Oiso T: Incidence of stomach cancer and its relation to dietary habits and nutrition in Japan between 1900 and 1975. Cancer Res 35: 3254-3258, 1975
271. Wynder EL, MacComack F, Hill P, et al: Nutrition and the etiology and prevention of breast cancer. Cancer Det Prev 1:293-310, 1976
272. Stocks P: Breast cancer anomalies. Br J Cancer 24:633-634, 1970
273. Phillips RL: Role of life-style and dietary habits in risk of cancer among Seventh-Day Adventists. Cancer Res 35:3513-3522, 1975
274. Miller AB: Role of nutrition in the etiology of breast cancer. Cancer 39:2704-2708, 1977
275. Miller AB, Kelly A, Choi NW, et al: A study of diet and breast cancer. Am J Epidemiol 107:499-509, 1978
276. Hill MJ, Goddard P, Williams REO: Gut bacteria and aetiology of cancer of the breast. Lancet 2:472-473, 1971
277. Stadel BV: Dietary iodine and risk of breast, endometrial, and ovarian cancer. Lancet 1:890-891, 1976
278. Cole P, Cramer D: Diet and cancer of the endocrine target organs. Cancer 40 (1 Suppl):434-437, 1977
279. MacDonald PC, Edman CD, Hemsell DL, et al: Effect of obesity on conversion of plasma an-drostenedione to estrone in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol 130:448-455, 1978
280. MacDonald PC, Siiteri PK: The relationship between the extraglandular production of estrone and the occurrence of endometrial neoplasia. Gynecol Oncol 2:259-263, 1974
281. Frisch RE, Revelle R: The height and weight of girls and boys at the time of initiation of the adolescent growth spurt in height and weight and the relationship to menarche. Hum Biol 43:140-159, 1971
282. Acheson RM: Maturation of the skeleton. In Human Development. Edited by F Faulkner. Philadelphia, PA, WB Saunders, 1966
283. Frisch RE: Critical weight at menarche, initiation of the adolescent growth spurt, and control of puberty. In Control of the Onset of Puberty. Edited by MM Grumbach, GD Grave, FE Mayer. New York, Wiley, 1974, pp 403-423
284. Bruch H: Obesity in childhood. I. Physical growth and development of obese children. Am J Dis Child 58:457-484, 1939
285. Forbes GB: Lean body mass and fat in obese children. Pediatrics 34:308-314, 1964
286. Nobécourt P: Obésité et Puberté. Presse Med 46:449- 452, 1938
287. Quade F: Obese Children—Anthropology and Environment. Copenhagen, Danish Science Press, Ltd, 1955
288. Wolff OH: Obesity in childhood. Q J Med 24:109-123, 1955
289. DeWaard F: Breast cancer incidence and nutritional status with particular reference to body weight and height. Cancer Res 35:3351-3356, 1975
290. MacMahon B: Formal discussion of "Breast cancer incidence and nutritional status with particular reference to body weight and height.” Cancer Res 35:3357-3358, 1975
291. DeWaard F, Halewijn EAB: A prospective study in general practice on breast-cancer risk in postmenopausal women. Int J Cancer 14:153-160, 1974
292. DeWaard F, Baandersvan-Halewijn EA, Huizinga J: The bimodal age distribution of patients with mammary carcinoma. Evidence for the existence of two types of human breast cancer. Cancer 17:141 — 151, 1964
293. McGregor DH, Land CE, Choi K, et al: Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950—1969. J Natl Cancer Inst 59:799-811, 1977
294. Jablon S, Kato H: Studies of mortality of A-bomb survivors. 5. Radiation dosé and mortality, 1950-1970. Radiat Res 50:649-698, 1972
295. Wanebo CK, Johnson KG, Sato K, et al: Breast cancer after exposure to the atomic bombings of Hiroshima and Nagasaki. N Engl J Med 279:667-671, 1968
296. Shore RE, Hempelmann LH, Kowaluk E, et al: Breast neoplasms in women treated with X-rays for acute postpartum mastitis. J Natl Cancer Inst 59:813-822, 1977
297. Mettler FA Jr, Hempelmann LH, Dutton AM, et al: Breast neoplasms in women treated with X-rays for acute postpartum mastitis. A pilot study. J Natl Cancer Inst 43:803 -811, 1969
298. Boice JD Jr, Monson RR: Breast cancer in women after repeated fluoroscopic examinations of the chest. J Natl Cancer Inst 59: 823-832, 1977
299. Mydren JA, Hiltz JE: Breast cancer following multiple fluoroscopies during artificial pneumothorax treatment of pulmonary tuberculosis. Can Med Assoc J 100:1032-1034, 1969
300. MacKenzie I: Breast cancer following multiple fluoroscopies. Br J Cancer 19:1—8, 1965
301. Casarett GW: Experimental radiation carcinogenesis. Prog Exp Tumor Res 7:48-82, 1965
302. Advisory Committee on the Biological Effects of Ionizing Radiation: Report on the Effects on Population of Exposure to Low Levels of Ionizing Radiation. Washington DC, National Academy of Sciences-National Research Council, 1972
303. Boice JD Jr, Land CE, Shore RE, et al: Risk of breast cancer following low-dose radiation exposure. Radiology 131:589-597, 1979
304. Boice JD Jr, Stone BJ: Interaction between radiation and other breast cancer risk factors. In Late Biological Effects of Ionizing Radiation. Vol I. Vienna, International Atomic Energy Agency, 1978, pp 231-249
305. Bross IDJ: Dose-response relationship in radiogenic breast cancer. J Natl Cancer Inst 60:727-728, 1978
306. Land CE, McGregor DH: Breast cancer incidence among atomic bomb survivors: Implications for radiobiologic risk at low doses. J Natl Cancer Inst 62:17-21, 1979
307. Bailar JC HI: Mammography: A contrary view. Ann Intern Med 84:77-84, 1976
308. Shapiro S: Evidence on screening for breast cancer from a randomized trial. Cancer 39: 2772-2782, 1977
309. Bailar JC III: Screening for early breast cancer: Pros and cons. Cancer 39:2783-2795, 1977
310. National Cancer Institute Ad Hoc Working Groups on Mammography Screening for Breast Cancer. First Reports and a Summary Report of their Joint Findings and Recommendations. DHEW Publication No NIH 77-1400, March, 1977
311. Wilkinson E, Clopton C, Gordonson J, et al: Mammographie parenchymal pattern and the risk of breast cancer. J Natl Cancer Inst 59:1397-1400, 1977
312. Wolfe JN: Breast patterns as an index of risk for developing breast cancer. AJR 126:1130-1139, 1976
313. Wolfe JN: Breast parenchymal patterns and ' their changes with age. Radiology 121: 545 - 552, 1976
314. Wolfe JN: A study of breast parenchyma by mammography in the normal woman and those with benign and malignant disease. Radiology 89:201-205, 1967
315. Wolfe JN: Risk for breast cancer development determined by mammographie parenchymal pattern. Cancer 37:2486-2492, 1976
316. Peyster RG, Kalisher L, Cole P: Mammographie parenchymal patterns and the prevalence of breast cancer. Radiology 125:387—391, 1977
317. Krook PM, Carlile T, Bush W, et al: Mammographie parenchymal patterns as a risk indicator for prevalent and incident cancer. Cancer 41:1093-1097, 1978
318. Mendell L, Rosenbloom M, Naimark A: Are breast patterns a risk index for breast cancer? A reappraisal. AJR 128:547, 1977
319. Rideout DF, Poon PY: Patterns of breast parenchyma in mammography. J Can Assoc Radiol 28:257-258, 1977
320. Wellings SR, Wolfe JN: Correlative studies of the histological and radiographic appearance of the breast parenchyma. Radiology 129: 299-306, 1978
321. Wellings SR, Jensen HM, Marcum RG: An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55: 231-273, 1975
322. Gass GH, Brown J, Okey AB: Carcinogenic effects of oral diethylstilbestrol on C3H male mice with and without the mammary tumor virus. J Natl Cancer Inst 53:1369-1370, 1974
323. Boston Collaborative Drug Surveillance Program. Reserpine and breast cancer. Lancet 2:669-671, 1974
324. Armstrong B, Stevens N, Doll R: Retrospective study of the association between use of rauwol-fia derivatives and breast cancer in English women. Lancet 2:672-675, 1974
325. Heinonen OP, Shapiro S, Tuonimen L, et al: Reserpine use in relation to breast cancer. Lancet 2:675-677, 1974
326. Henderson M: Reserpine and breast cancer: A review. In Epidemiological Evaluation of Drugs. Proceedings of the International Symposium on Epidemiological Evaluation of Drugs, Milan, Italy, May 2-4, 1977. Edited by F Colombo, S Shapiro, D Slone, et al. Littleton, MA, PSG Publishing Company, 1977
327. Mack TM, Henderson BE, Gerkins VR, et al: Reserpine and breast cancer in a retirement community. N Engl J Med 292:1366-1371, 1975
328. O’Fallon WM, Labarthe DR, Kurland LT: Rauwolfia derivatives and breast cancer. A case-control study in Olmstead County, Minnesota. Lancet 2:292-296, 1975
329. Laska EM, Siegel C, Meisner M, et al: Matched-pairs study of reserpine use and breast cancer. Lancet 2:296-300, 1975
330. Lilienfeld AM, Chang L, Thomas DB, et al: Rauwolfia derivatives and breast cancer. Johns Hopkins Med J 139:41—50, 1976
331. Armstrong B, Skegg D, White G, et al: Rauwolfia derivatives and breast cancer in hypertensive women. Lancet 2:8-12, 1976
332. Aromaa A, Hakama M, Hakulinen T, et al: Breast cancer and use of rauwolfia and other antihypertensive agents in hypertensive patients: A nationwide case-control study in Finland. Int J Cancer 18:727- 738, 1976
333. Kewitz H, Jesdinsky HJ, Shröter PM, et al: Reserpine and breast cancer in West Germany. Eur J Clin Pharmacol 11:79-83, 1977
334. Christopher LJ, Crooks J, Davidson JF, et al: A multicentre study of rauwolfia dérivâtes and breast cancer. Eur J Clin Pharmacol 11: 409-417, 1977
335. Labarthe DR: Methodologie variation in case-control studies of reserpine and breast cancer. J Chronic Dis 32:95-104, 1979
336. Ames BN, Kämmen HO, Yamasaki E: Hair dyes are mutagenic: Identification of a variety of mutagenic ingredients. Proc Natl Acad Sei USA 72:2423-2427, 1975
337. Searle CE, Hamden DG, Venitt S, et al: Carcinogenicity and mutagenicity tests of some hair colourants and constituents. Nature 255:506-507, 1975
338. Shore RE, Pasternack BS, Thiessen EU, et al: A case-control study of hair dye use and breast cancer. J Natl Cancer Inst 62:277-283, 1979
339. Kinlen LJ, Harris R, Garrod A, et al: Use of hair dyes by patients with breast cancer: A case-control study. Br Med J 2:366-368, 1977
340. Hennekens CH, Speizer FE, Rosner B, et al: Hair dyes and human cancer. Abstract. Am J Epidemiol 108:240-241, 1978
341. Walrath J: Cancer incidence amongst cosmetologists. Doctoral dissertation, Yale University, 1977
342. Menck HR, Pike MC, Henderson BE, et al: Lung cancer risk among beauticians and other female workers: Brief communication. J Natl Cancer Inst 59:1423-1425, 1977
343. Shafer N, Shafer RW: Potential of carcinogenic. effects of hair dyes. NY State J Med 76: 394-396, 1976
344. Schottenfeld D, Lilienfeld AM: Some epidemiological features of breast cancer among males. J Chronic Dis 16:71-81, 1963
345. Moolgavkar SH, Lee JA, Hade RD: Comparison of age-specific mortality from breast cancer in males in the United States and Japan. J Natl Cancer Inst 60:1223-1225, 1978
346. Schottenfeld D, Lilienfeld AM, Diamond H: Some observations on the epidemiology of breast cancer among males. Am J Public Health 53:890-897, 1963
347. Keller AZ: Demographic, clinical and survivorship characteristics of males with primary cancer of the breast. Am J Epidemiol 85:183-199, 1967
348. Peltokallio P, Kalima TV: Malignant tumours of the male breast in Finland. A report of 51 cases. Br J Cancer 23:480-487, 1969
349. Modan B, Mintz U, Finkelman J: Male breast cancer in Israel. Selected epidemiological and clinical aspects. J Chronic Dis 23:55—60, 1970
350. Langlands AO, Maclean N, Kerr GR: Carcinoma of the male breast: Report of a series of 88 cases. Clin Radiol 27:21-25, 1976
351. Holleb AI, Freeman HP, Farrow JH: Cancer of the male breast. Part II. NY State Med J 68:656-663, 1968
352. El-Gazayerli MM, Abdel-Aziz AS: On bilhar-ziasis and male breast cancer in Egypt: A preliminary report and review of the literature. Br J Cancer 17:566-571, 1963
353. Symmers W St C: Carcinoma of breast in transsexual individuals after surgical and hormonal interference with primary and secondary sex characteristics. Br Med J 2:83-85, 1968
354. Scheike O, Visfeldt J, Petersen B: Male breast cancer. 3. Breast carcinoma in association with the Klinefelter syndrome. Acta Pathol Microbiol Scand Section A 81:357-358, 1973
355. Everson RB, Li FP, Fraumeni JF Jr, et al: Familial male breast cancer. Lancet 1:9-12, 1976
356. WHO: Steroid contraception and the risk of neoplasia. WHO Technical Report Series 619. Geneva, WHO, 1978
357. Mack TM, Pike MC, Henderson BE, et al: Estrogens and endometrial cancer in a retirement community. N Engl J Med 294: 1262-1267, 1976
358. Stadel BV, Weiss N: Characteristics of menopausal women: A survey of King and Pierce Counties in Washington, 1973-1974. Am J Epidemiol 102:209-216, 1975